Boucai Laura, Bernet Victor, Shaha Ashok, Shindo Maisie L, Stack Brendan C, Tuttle Robert M
Division of Endocrinology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
Division of Endocrinology, Department of Medicine, Mayo Clinic Jacksonville, Florida.
J Surg Oncol. 2017 Sep;116(3):269-274. doi: 10.1002/jso.24673. Epub 2017 May 17.
We reevaluate current treatment recommendations of papillary thyroid microcarcinomas taking into account the indolent behavior of these tumors, and the potential morbidity that may result from an unnecessary surgery. The goals of this communication are to: 1) provide surgeons and endocrinologists with the most up-to-date evidence on management of microcarcinomas, 2) outline appropriate instances for active surveillance, and 3) describe the role of surgical interventions for microcarcinomas including lobectomy, total thyroidectomy, and central neck dissection.
我们重新评估了目前甲状腺微小乳头状癌的治疗建议,同时考虑到这些肿瘤的惰性生物学行为以及不必要手术可能导致的潜在发病率。本交流的目的是:1)为外科医生和内分泌科医生提供关于微小癌管理的最新证据;2)概述进行主动监测的合适情况;3)描述包括甲状腺叶切除术、全甲状腺切除术和中央区颈淋巴结清扫术在内的微小癌手术干预的作用。